Calcium-Induced Regulation of Sanghuangporus baumii Growth and the Biosynthesis of Its Triterpenoids

<i>Sanghuangporus baumii</i>, a fungus used in traditional Chinese medicine, produces important pharmacological compounds such as triterpenoids, but at levels significantly lower than those required for medical use. This study investigated the effects of various concentrations of Ca<sup>2+</sup> on <i>S. baumii</i> mycelial growth and the heterologous biosynthesis of <i>S. baumii</i> triterpenoids. Under induction by 10 mM Ca<sup>2+</sup>, the growth rate (0.39 cm/d) and biomass (4.48 g/L) of <i>S. baumii</i> mycelia were 1.03% and 10.05% higher than those in the 0 mM Ca<sup>2+</sup>-treatment group, respectively. In contrast, 200 mM Ca<sup>2+</sup> significantly inhibited the growth rate and biomass of the mycelia. Notably, the total triterpenoid content reached its peak (17.71 mg/g) in the 200 mM Ca<sup>2+</sup>-treatment group, with a significant increase in the Ca<sup>2+</sup> content (3869.97 µg/g) in the mycelia. Subsequently, the differential metabolic pathways and related genes between the <i>S. baumii</i> groups were examined using transcriptomic analysis. The results indicated that the increase in the growth rate and biomass of <i>S. baumii</i> mycelia was primarily due to elevated soluble sugar content, whereas the growth inhibition was associated with the toxic effects of H<sub>2</sub>O<sub>2</sub>. The observed differences in triterpenoid content were mainly attributed to the activation of the terpenoid backbone biosynthesis pathway and the <i>AACT</i> gene. Finally, the <i>AACT</i> gene was cloned and transformed into yeast cells, thus creating strain Sc-AA1. Upon treatment at the optimal Ca<sup>2+</sup> concentration, the squalene content of strain Sc-AA1 reached 0.78 mg/g, 2.89-fold higher than that in the control group. These findings are significant for the heterologous biosynthesis of triterpenoids from <i>S. baumii</i>. Our study demonstrates the feasibility of producing triterpenoids in <i>Saccharomyces cerevisiae</i> and provides a foundation for future optimization toward achieving industrially relevant yields.

Authors

Institutions

Publication Details

Journal
Journal of Fungi
Published
2025-03-20
DOI
https://doi.org/10.3390/jof11030238
Primary Topic
Plant biochemistry and biosynthesis
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Calcium-Induced Regulation of Sanghuangporus baumii Growth and the Biosynthesis of Its Triterpenoids

Zengcai Liu, Shiyuan Wang, Ying Yu, Li Zou
Journal of Fungi
Plant biochemistry and biosynthesis
article

Calcium-Induced Regulation of Sanghuangporus baumii Growth and the Biosynthesis of Its Triterpenoids

Zengcai Liu, Shiyuan Wang, Ying Yu, Li Zou
article en

Abstract

<i>Sanghuangporus baumii</i>, a fungus used in traditional Chinese medicine, produces important pharmacological compounds such as triterpenoids, but at levels significantly lower than those required for medical use. This study investigated the effects of various concentrations of Ca<sup>2+</sup> on <i>S. baumii</i> mycelial growth and the heterologous biosynthesis of <i>S. baumii</i> triterpenoids. Under induction by 10 mM Ca<sup>2+</sup>, the growth rate (0.39 cm/d) and biomass (4.48 g/L) of <i>S. baumii</i> mycelia were 1.03% and 10.05% higher than those in the 0 mM Ca<sup>2+</sup>-treatment group, respectively. In contrast, 200 mM Ca<sup>2+</sup> significantly inhibited the growth rate and biomass of the mycelia. Notably, the total triterpenoid content reached its peak (17.71 mg/g) in the 200 mM Ca<sup>2+</sup>-treatment group, with a significant increase in the Ca<sup>2+</sup> content (3869.97 µg/g) in the mycelia. Subsequently, the differential metabolic pathways and related genes between the <i>S. baumii</i> groups were examined using transcriptomic analysis. The results indicated that the increase in the growth rate and biomass of <i>S. baumii</i> mycelia was primarily due to elevated soluble sugar content, whereas the growth inhibition was associated with the toxic effects of H<sub>2</sub>O<sub>2</sub>. The observed differences in triterpenoid content were mainly attributed to the activation of the terpenoid backbone biosynthesis pathway and the <i>AACT</i> gene. Finally, the <i>AACT</i> gene was cloned and transformed into yeast cells, thus creating strain Sc-AA1. Upon treatment at the optimal Ca<sup>2+</sup> concentration, the squalene content of strain Sc-AA1 reached 0.78 mg/g, 2.89-fold higher than that in the control group. These findings are significant for the heterologous biosynthesis of triterpenoids from <i>S. baumii</i>. Our study demonstrates the feasibility of producing triterpenoids in <i>Saccharomyces cerevisiae</i> and provides a foundation for future optimization toward achieving industrially relevant yields.

Journal of FungiVol. 11(3)
Northeast Forestry University (CN)
National Natural Science Foundation of China
Openalex Percentile: Top 95%
Plant biochemistry and biosynthesis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.